CALAN SR
Pronunciation: ver-AP-a-mil

What it isL-type calcium-channel blocker that slows AV conduction and relaxes arteries; hypertension, angina, and supraventricular arrhythmias.
Why this oneIts strong AV-nodal effect provides rate control that dihydropyridine calcium-channel blockers cannot.
What limits itConstipation, bradycardia, and heart block limit use; avoid systolic heart failure and watch CYP3A4 and P-gp interactions.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Hypertension | Adults | 180 mg once daily in the morning (120 mg if elderly/small) | Titrate to 240 mg QD, then 360 mg/day, then 480 mg/day | 480 mg/day |
Titration Upward titration based on efficacy/safety evaluated weekly (and ~24 h after previous dose).
Renal Administer cautiously; ~70% excreted in urine, not removed by hemodialysis; monitor for PR prolongation/overdosage.
Hepatic Severe liver dysfunction: administer ~30% of the normal dose; monitor.
Available strengths
Pregnancy No evidence of teratogenicity in animals; use only if clearly needed (crosses placenta).
Lactation Undefined.
| Strength | #/mo | generic $/mo | CostPlus | |
|---|---|---|---|---|
| 120 mg | ER tab | 30 qd | $5.33 | offered |
| 180 mg | ER tab | 30 qd | $5.73 | offered |
| 240 mg | ER tab | 30 qd | $5.28 | offered |
Other forms: Verapamil (CALAN)
NO BOXED WARNINGS
Principal riskHeart failure, hypotension and AV block